NIIMBL receives $83M to tackle vaccine development

Students Lauren Cordova (left) and Sofia Alfieri work together in an NIIMBL lab at the University of Delaware STAR Campus. A new batch of federal funds will support NIIMBL’s work into vaccine development. | DBT PHOTO BY ERIC CROSSAN NEWARK – The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) was

Already a subscriber? Log in

To continue reading this article ...

Subscribe to Delaware Business Times right now and get access to subscriber-only content like this article. Plus get 24 issues of DBT via print or digital, special bonus issues, and discounted registration for our in-person events.

– Digital Partners -